Table 7.
ADMET prediction of ligands 1, 2, and 3.
Pharmacokinetic Properties | Parameters | Ligands | ||
---|---|---|---|---|
1 | 2 | 3 | ||
Absorption | Water solubility | −4.674 log mol/L | −7.66 log mol/L | −6.673 log mol/L |
Intestinal absorption | 89.583% absorbed | 90.281% absorbed | 96.151% absorbed | |
Skin permeability | −2.7 log Kp | −2.792 log Kp | −2.781 log Kp | |
Distribution | Volume distribution (VDss) | 0.366 log L/kg | 0.11 log L/kg | 0.18 log L/kg |
BBB permeability | −0.062 log BB | −0.414 log BB | 0.799 log BB | |
CNS permeability | −2.12 log PS | −1.36 log PS | −1.737 log PS | |
Metabolism | Inhibitor of: | Yes | Yes | No |
CYP1A2 | ||||
CYP2C19 | Yes | No | No | |
CYP2C9 | Yes | No | No | |
CYP2D6 | No | No | No | |
CYP3A4 | No | No | No | |
Excretion | Total Clearance | 0.418 log mL/min/kg | 1.861 log mL/min/kg | 0.618 log mL/min/kg |
Acute oral toxicity | Lethal dose 50% | 2.331 mol/kg | 1.654 mol/kg | 2.375 mol/Kg |
Skin sensitization | No | Yes | No |